Vergoeding 2016-2020 voor ATC-subgroep N06AA : Niet-selectieve monoamine-heropnameremmers
- Raming voor de totale Zvw-populatie
| 2016 | 2017 | 2018 | 2019 | 2020 | |
|---|---|---|---|---|---|
| N06AA02 Imipramine | 195.350 | 169.940 | 145.960 | 141.240 | 157.560 |
| N06AA04 Clomipramine | 1.153.600 | 1.115.400 | 1.136.000 | 1.156.200 | 1.122.900 |
| N06AA09 Amitriptyline | 2.133.200 | 2.093.800 | 2.343.700 | 2.798.600 | 2.898.900 |
| N06AA10 Nortriptyline (Nortrilen ®) | 3.546.500 | 3.684.000 | 3.847.400 | 3.750.700 | 3.455.900 |
| N06AA12 Doxepine (Sinequan ®) | 102.310 | 95.038 | 91.149 | 82.684 | 20.334 |
| N06AA16 Dosulepine (Prothiaden ®) | 63.605 | 54.093 | 47.055 | 45.797 | 53.020 |
| N06AA21 Maprotiline | 71.845 | 64.790 | 60.317 | 50.245 | 63.450 |
| Totaal | 7.266.410 | 7.277.061 | 7.671.581 | 8.025.466 | 7.772.064 |